Cargando…

A randomized single-blind controlled trial of a prototype digital polytherapeutic for tinnitus

OBJECTIVE: This randomized single-blind controlled trial tested the hypothesis that a prototype digital therapeutic developed to provide goal-based counseling with personalized passive and active game-based sound therapy would provide superior tinnitus outcomes, and similar usability, to a popular p...

Descripción completa

Detalles Bibliográficos
Autores principales: Searchfield, Grant D., Sanders, Philip J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9389120/
https://www.ncbi.nlm.nih.gov/pubmed/35989940
http://dx.doi.org/10.3389/fneur.2022.958730
_version_ 1784770370188869632
author Searchfield, Grant D.
Sanders, Philip J.
author_facet Searchfield, Grant D.
Sanders, Philip J.
author_sort Searchfield, Grant D.
collection PubMed
description OBJECTIVE: This randomized single-blind controlled trial tested the hypothesis that a prototype digital therapeutic developed to provide goal-based counseling with personalized passive and active game-based sound therapy would provide superior tinnitus outcomes, and similar usability, to a popular passive sound therapy app over a 12 week trial period. METHODS: The digital therapeutic consisted of an app for iPhone or Android smartphone, Bluetooth bone conduction headphones, neck pillow speaker, and a cloud-based clinician dashboard to enable messaging and app personalization. The control app was a popular self-help passive sound therapy app called White Noise Lite (WN). The primary outcome measure was clinically meaningful change in Tinnitus Functional Index (TFI) between baseline and 12 weeks of therapy. Secondary tinnitus measures were the TFI total score and subscales across sessions, rating scales and the Client Oriented Scale of Improvement in Tinnitus (COSIT). Usability of the US and WN interventions were assessed using the System Usability Scale (SUS) and the mHealth App Usability Questionnaire (MAUQ). Ninety-eight participants who were smartphone app users and had chronic moderate-severe tinnitus (>6 months, TFI score > 40) were enrolled and were randomly allocated to one of the intervention groups. Thirty-one participants in the USL group and 30 in the WN group completed 12 weeks of trial. RESULTS: Mean changes in TFI for the USL group at 6 (16.36, SD 17.96) and 12 weeks (17.83 points, SD 19.87) were clinically meaningful (>13 points reduction), the mean change in WN scores were not clinically meaningful (6 weeks 10.77, SD 18.53; 12 weeks 10.12 points, SD 21.36). A statistically higher proportion of USL participants achieved meaningful TFI change at 6 weeks (55%) and 12 weeks (65%) than the WN group at 6 weeks (33%) and 12 weeks (43%). Mean TFI, rating and COSIT scores favored the US group but were not statistically different from WN. Usability measures were similar for both groups. CONCLUSIONS: The USL group demonstrated a higher proportion of responders than the WN group. The usability of the USL therapeutic was similar to the established WN app. The digital polytherapeutic demonstrated significant benefit for tinnitus reduction supporting further development.
format Online
Article
Text
id pubmed-9389120
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-93891202022-08-20 A randomized single-blind controlled trial of a prototype digital polytherapeutic for tinnitus Searchfield, Grant D. Sanders, Philip J. Front Neurol Neurology OBJECTIVE: This randomized single-blind controlled trial tested the hypothesis that a prototype digital therapeutic developed to provide goal-based counseling with personalized passive and active game-based sound therapy would provide superior tinnitus outcomes, and similar usability, to a popular passive sound therapy app over a 12 week trial period. METHODS: The digital therapeutic consisted of an app for iPhone or Android smartphone, Bluetooth bone conduction headphones, neck pillow speaker, and a cloud-based clinician dashboard to enable messaging and app personalization. The control app was a popular self-help passive sound therapy app called White Noise Lite (WN). The primary outcome measure was clinically meaningful change in Tinnitus Functional Index (TFI) between baseline and 12 weeks of therapy. Secondary tinnitus measures were the TFI total score and subscales across sessions, rating scales and the Client Oriented Scale of Improvement in Tinnitus (COSIT). Usability of the US and WN interventions were assessed using the System Usability Scale (SUS) and the mHealth App Usability Questionnaire (MAUQ). Ninety-eight participants who were smartphone app users and had chronic moderate-severe tinnitus (>6 months, TFI score > 40) were enrolled and were randomly allocated to one of the intervention groups. Thirty-one participants in the USL group and 30 in the WN group completed 12 weeks of trial. RESULTS: Mean changes in TFI for the USL group at 6 (16.36, SD 17.96) and 12 weeks (17.83 points, SD 19.87) were clinically meaningful (>13 points reduction), the mean change in WN scores were not clinically meaningful (6 weeks 10.77, SD 18.53; 12 weeks 10.12 points, SD 21.36). A statistically higher proportion of USL participants achieved meaningful TFI change at 6 weeks (55%) and 12 weeks (65%) than the WN group at 6 weeks (33%) and 12 weeks (43%). Mean TFI, rating and COSIT scores favored the US group but were not statistically different from WN. Usability measures were similar for both groups. CONCLUSIONS: The USL group demonstrated a higher proportion of responders than the WN group. The usability of the USL therapeutic was similar to the established WN app. The digital polytherapeutic demonstrated significant benefit for tinnitus reduction supporting further development. Frontiers Media S.A. 2022-08-05 /pmc/articles/PMC9389120/ /pubmed/35989940 http://dx.doi.org/10.3389/fneur.2022.958730 Text en Copyright © 2022 Searchfield and Sanders. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neurology
Searchfield, Grant D.
Sanders, Philip J.
A randomized single-blind controlled trial of a prototype digital polytherapeutic for tinnitus
title A randomized single-blind controlled trial of a prototype digital polytherapeutic for tinnitus
title_full A randomized single-blind controlled trial of a prototype digital polytherapeutic for tinnitus
title_fullStr A randomized single-blind controlled trial of a prototype digital polytherapeutic for tinnitus
title_full_unstemmed A randomized single-blind controlled trial of a prototype digital polytherapeutic for tinnitus
title_short A randomized single-blind controlled trial of a prototype digital polytherapeutic for tinnitus
title_sort randomized single-blind controlled trial of a prototype digital polytherapeutic for tinnitus
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9389120/
https://www.ncbi.nlm.nih.gov/pubmed/35989940
http://dx.doi.org/10.3389/fneur.2022.958730
work_keys_str_mv AT searchfieldgrantd arandomizedsingleblindcontrolledtrialofaprototypedigitalpolytherapeuticfortinnitus
AT sandersphilipj arandomizedsingleblindcontrolledtrialofaprototypedigitalpolytherapeuticfortinnitus
AT searchfieldgrantd randomizedsingleblindcontrolledtrialofaprototypedigitalpolytherapeuticfortinnitus
AT sandersphilipj randomizedsingleblindcontrolledtrialofaprototypedigitalpolytherapeuticfortinnitus